Modulation of immunoproteasome subunits by liposomal lipid

被引:13
作者
Steers, Nicholas J. [1 ]
Alving, Carl R. [1 ]
Rao, Mangala [1 ]
机构
[1] Walter Reed Army Inst Res, US Mil HIV Res Program, Div Retrovirol, Rockville, MD 20850 USA
关键词
immunoproteasomes; liposomal lipid A; dendritic cells; macrophages;
D O I
10.1016/j.vaccine.2008.03.065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Liposomes are phospholipid vesicles that have been used as carriers of antigens and adjuvants. Lipid A, the endotoxic moiety of Gram-negative bacterial lipopolysaccharicle is a potent adjuvant and incorporation into liposomes essentially reduces the endotoxic activity of lipid A. In this study, we analyzed the effect of liposomal lipid A [L(LA)] on the MHC class I antigen processing machinery in murine antigen presenting cells (APCs). L(LA) enhanced the surface expression of MHC class I, class II, CD80, and CD86 molecules, induced the secretion of IFN-gamma, IL-12p40, TNF-alpha and IL-10, and caused a shift in the proteasome profile from constitutive to immunoproteasomes as observed by the induction of beta 2i, beta 5i, PA28 alpha, and PA28 beta subunits. L(LA) acts through the production of IFN-gamma as demonstrated with APCs generated from IFN-gamma knockout mice. L(LA) therefore appears to act as an intracellular adjuvant by upregulating the antigen processing machinery, which could result in efficient antigen presentation. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2849 / 2859
页数:11
相关论文
共 54 条
[1]   LIPOPOLYSACCHARIDE, LIPID-A, AND LIPOSOMES CONTAINING LIPID-A AS IMMUNOLOGICAL ADJUVANTS [J].
ALVING, CR .
IMMUNOBIOLOGY, 1993, 187 (3-5) :430-446
[2]   LIPOSOMES AS CARRIERS OF ANTIGENS AND ADJUVANTS [J].
ALVING, CR .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 140 (01) :1-13
[3]   LIPOSOMES AS CARRIERS OF PEPTIDE ANTIGENS - INDUCTION OF ANTIBODIES AND CYTOTOXIC T-LYMPHOCYTES TO CONJUGATED AND UNCONJUGATED PEPTIDES [J].
ALVING, CR ;
KOULCHIN, V ;
GLENN, GM ;
RAO, M .
IMMUNOLOGICAL REVIEWS, 1995, 145 :5-31
[4]  
ALVING CR, 2008, VACCINE IN PRESS
[5]   Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents [J].
Baldridge, JR ;
McGowan, P ;
Evans, JT ;
Cluff, C ;
Mossman, S ;
Johnson, D ;
Persing, D .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (07) :1129-1138
[6]   Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus [J].
Basler, M ;
Youhnovski, N ;
van den Broek, M ;
Przybylski, M ;
Groettrup, M .
JOURNAL OF IMMUNOLOGY, 2004, 173 (06) :3925-3934
[7]   Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation [J].
Chapiro, J ;
Claverol, S ;
Piette, F ;
Ma, WB ;
Stroobant, V ;
Guillaume, B ;
Gairin, JE ;
Morel, S ;
Burlet-Schiltz, O ;
Monsarrat, B ;
Boon, T ;
Van den Eynde, BJ .
JOURNAL OF IMMUNOLOGY, 2006, 176 (02) :1053-1061
[8]   Immunoproteasomes shape immunodominance hierarchies of antiviral CD8+ T cells at the levels of T cell repertoire and presentation of viral antigens [J].
Chen, WS ;
Norbury, CC ;
Cho, YJ ;
Yewdell, JW ;
Bennink, JR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1319-1326
[9]   The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells [J].
De Becker, G ;
Moulin, V ;
Pajak, B ;
Bruck, C ;
Francotte, M ;
Thiriart, C ;
Urbain, J ;
Moser, M .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (06) :807-815
[10]   Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes [J].
Deol, Parampal ;
Zaiss, Dietmar M. W. ;
Monaco, John J. ;
Sijts, Alice J. A. M. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (12) :7557-7562